Graded A to F on human evidence · reviewed November 20, 2026
Best Peptide for Muscle (2026)
Peptides sold for muscle, graded on the human evidence for lean mass and strength. The human trials are small and were done in older adults.
By Julian Caraulani · prices checked
For lean muscle and strength, Sermorelin has the strongest human evidence of the peptides US programs sell: grade B (some human evidence). MOTS-c grades D. None is FDA-approved for muscle when compounded. Grades follow our published rubric; prices come from each program's own page, with the date we read it.
Price checked Nov 19 · Medication included · No email needed
Muscle peptides, graded
Strongest evidence first. The grade covers lean muscle and strength only; the same peptide can grade differently for another goal.
| Grade | Peptide | FDA status | Lowest price |
|---|---|---|---|
| B | Sermorelin Some human evidence Former brand GEREF. FDA found it was not withdrawn from sale for safety or effectiveness reasons. Not on the 14 May 2026 category list, and no source here states its compounding status today. | Former brand GEREF. FDA found it was not withdrawn from sale for safety or effectiveness reasons. Not on the 14 May 2026 category list, and no source here states its compounding status today. | $94/mo Idun Rx, 17 programs |
| D | MOTS-c Preclinical only Interim HHS enforcement discretion, acetate form, injection routes only. Not FDA-approved. | Interim HHS enforcement discretion, acetate form, injection routes only. Not FDA-approved. | $129/mo HealthRX, 3 programs |
Sermorelin for muscle: grade B
Some human evidence
What the human evidence shows. A placebo-controlled trial of 19 adults found more lean body mass in men only. A second small trial in 11 older men found gains in two of six strength tests but no change in muscle measured by scan.
Form. Both trials used GHRH(1-29), the same 29-amino-acid sequence as sermorelin, in adults aged 55 and over.
Sources: Khorram 1997, J Clin Endocrinol Metab · Vittone 1997, Metabolism. Read November 20, 2026.
Regulatory status: Former brand GEREF. FDA found it was not withdrawn from sale for safety or effectiveness reasons. Not on the 14 May 2026 category list, and no source here states its compounding status today.
“were not withdrawn from sale for reasons of safety or effectiveness” Federal Register, 4 Mar 2013: GEREF (sermorelin acetate) determination, read November 6, 2026
Sermorelin programs, cheapest first
| Program | Plan | Price | Score | Visit |
|---|---|---|---|---|
Sermorelin, 12 months | Sermorelin, 12 months | $94/moread November 19, 2026 | 8.7/10 | Visit |
Sermorelin injection | Sermorelin injection | $99/moread November 19, 2026 | 8.7/10 | Visit |
Sermorelin injection, from price | Sermorelin injection, from price | $99/moread November 19, 2026 | 8.3/10 | Visit |
Sermorelin, starting price | Sermorelin, starting price | $99/moread November 19, 2026 | 7.6/10 | Visit |
Sermorelin lozenge, 30-day supply | Sermorelin lozenge, 30-day supply | $99/moread November 19, 2026 | 7.4/10 | Visit |
12 more on cheapest sermorelin · Sermorelin cost
MOTS-c for muscle: grade D
Preclinical only
What the human evidence shows. Studies in people have measured the body's own MOTS-c levels, for example after exercise. We found no published trial that gave MOTS-c to people. FDA says it lacks safety information on MOTS-c in people.
Sources: FDA: bulk drug substances that may present significant safety risks. Read November 20, 2026.
Regulatory status: Interim HHS enforcement discretion, acetate form, injection routes only. Not FDA-approved.
“enforcement discretion for MOTS-c acetate is appropriate subcutaneous or intramuscular injectable dosage forms” HHS Enforcement Discretion Policy with Appendices A and B, read November 18, 2026
MOTS-c programs, cheapest first
| Program | Plan | Price | Score | Visit |
|---|---|---|---|---|
MOTS-c injection, 12-month plan | MOTS-c injection, 12-month plan | $129/moread November 19, 2026 | 8.3/10 | Visit |
MOTS-c injection (preorder) | MOTS-c injection (preorder) | $199/moread November 19, 2026 | 8.0/10 | Visit |
MOTS-c injection | MOTS-c injection | $274.50/moread November 20, 2026 | 8.3/10 | Visit |
Every plan on cheapest MOTS-c · MOTS-c cost
How these grades are set
One fixed rubric for every goal: A means FDA-approved for the goal, or at least two randomized trials in people that found a benefit. B means at least one human trial, or approval outside the US backed by trials. C means pilot or foreign-only human data. D means preclinical studies only. F means human trials found no benefit. When trials disagree, the grade drops one step. Read the full rubric.
We do not publish doses, schedules or combinations. A licensed prescriber decides whether any peptide suits you. Compounded peptides are not FDA-approved products.
Questions about peptides for muscle
What is the best peptide for muscle?
Of the peptides the programs we track sell, sermorelin has the most human evidence for muscle (grade B): a small trial found more lean mass in older men. MOTS-c has preclinical studies only (grade D).
Does MOTS-c build muscle in people?
We found no published trial that gave MOTS-c to people. The studies in people measured the body's own MOTS-c levels, so it grades D for muscle.
How do you grade peptides for muscle?
With one fixed A to F rubric for every goal: A means FDA-approved for the goal or at least two randomized trials in people that found a benefit; B at least one human trial or approval outside the US backed by trials; C pilot or foreign-only human data; D preclinical only; F human trials found no benefit. The full rules are on our methodology page.
Do you say how much to take?
No. We publish evidence grades, regulatory status and prices only. We do not publish doses, schedules or combinations. A licensed prescriber decides whether any of these suits you and how it is used.